H. Schwarzenbach
Nature Reviews. Cancer · 2011–2014
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom H. Schwarzenbach trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts H. Schwarzenbach overall
Papers from H. Schwarzenbach's perspective
Ordered by how strongly the researchers H. Schwarzenbach trusts endorse each paper. Same corpus, a different order for every researcher.
- MicroRNA expression profiles classify human cancers (Nature)
- The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. (Clinical Chemistry)
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening (Gut)
- A novel and universal method for microRNA RT-qPCR data normalization (Genome Biology)
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis (Cancer Science)
- Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
- Genomic DNA methylation: the mark and its mediators.
- The first 30 years of p53: growing ever more complex (Nature Reviews. Cancer)
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
- Circulating nucleic acids (CNAs) and cancer--a survey. (Biochimica et Biophysica Acta)
Their papers
- Cell-free nucleic acids as biomarkers in cancer patients (2011) — 2,804 citations
- Clinical relevance of circulating cell-free microRNAs in cancer (2014) — 1,025 citations